METCAM/MUC18 expression was consistently higher in cell lines established from more malignant breast carcinomas, such as SK-BR-3 and MDA-MB-468, than cell lines from less malignant breast carcinomas, such as MCF7 and MDA-MB-231. Here, MCAM is linked to breast carcinoma.